Compositions and methods of treating retinal disease
US10202348B2 · kind B2 · utility
25Cited by
8References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 3, 2018 |
| Grant date | Feb 12, 2019 |
| Priority date | — |
| Expiry date | Jan 3, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D333/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.